Adage Capital Partners
HAE icon

Adage Capital Partners’s Haemonetics HAE Stock Holding History

Adage Capital Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200,000
Closed -$10.6M – 1105
2021
Q4 		$10.6M Buy
200,000
+100,000
+100% +$6.09M 0.02% 672
2021
Q3 		$7.06M Buy
+100,000
New +$6.31M 0.01% 786
2020
Q2 		– Sell
-250,000
Closed -$24.9M – 769
2020
Q1 		$24.9M Buy
+250,000
New +$27.1M 0.07% 275

Other funds holding HAE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Adage Capital Partners's HAE Position: Q1 2022 in Review

Adage Capital Partners sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 200,000 shares — an estimated $10.6M sold.

Adage Capital Partners first reported a position in HAE in Q1 2020 and held it in 3 quarters. The position peaked at $24.9M in Q1 2020. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

  • Adage Capital Partners reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
  • Adage Capital Partners sold 200,000 Haemonetics shares in Q1 2022, an estimated $10.6M.
  • Adage Capital Partners first reported a position in Haemonetics in Q1 2020 and held it in 3 quarters.
  • Adage Capital Partners's Haemonetics position peaked at $24.9M in Q1 2020.
  • 242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on Adage Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.